{{Rsnum
|rsid=7164902
|Gene=SLC12A6
|Chromosome=15
|position=34258881
|Orientation=plus
|GMAF=0.2704
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC12A6
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 35.4 | 60.2
| HCB | 8.8 | 48.9 | 42.3
| JPT | 11.5 | 52.2 | 36.3
| YRI | 8.8 | 31.3 | 59.9
| ASW | 1.8 | 31.6 | 66.7
| CHB | 8.8 | 48.9 | 42.3
| CHD | 8.3 | 35.8 | 56.0
| GIH | 10.9 | 54.5 | 34.7
| LWK | 4.5 | 31.8 | 63.6
| MEX | 1.7 | 34.5 | 63.8
| MKK | 6.4 | 23.1 | 70.5
| TSI | 8.8 | 41.2 | 50.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21245421
|Title=Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}